- Fee assured
- Verified this account
Dr Ien Chan MBChB, MD, FRCP is fully accredited with the General Medical Council and is on the specialist register.
He sees patients with general skin disorders such as acne, eczema, psoriasis, hair loss and vitiligo as well as screening and treatment of skin cancers and mole checks. His other specialist interests include paediatric dermatology, HIV-associated skin diseases and male genital dermatoses.
He trained in dermatology at St John's Institute of Dermatology, St Mary's Hospital and Chelsea and Westminster Hospital. He has researched the role of extracellular matrix protein 1 in human skin in the Genetic Skin Disease Group, King's College London. This resulted in a research MD degree, numerous publications in high impact factor journals and presentations at national and international dermatology and scientific meetings.
He is an experienced dermatologist, having worked over ten years as a consultant at St Mary's Hospital, part of the Imperial College Healthcare NHS Trust, the UK's first Academic Health Science Centre.
Areas of interest
General dermatology including acne, eczema, psoriasis, hair loss and vitiligo; Screening and treatment of skin cancers; Paediatric dermatology; HIV-associated skin diseases; Male genital skin disorders.
- Jonathan Arrowood / Lynne Page
- Bupa Cromwell Hospital 164-178 Cromwell Road London SW5 0TU
- 07940 356405
- 07850 554808
Current NHS consultant posts held
St Mary's Hospital
Imperial College Healthcare NHS Trust
(Additional) Languages spoken
- English - Native or bilingual
Chan I. The role of extracellular matrix protein 1 in human skin. Clin Exp Dermatol 2004; 29: 52-6.
Chan I, Oyama N, Hamada T et al. Rapid diagnosis of lipoid proteinosis using an anti-extracellular matrix protein 1 (ECM1) antibody. J Dermatol Sci 2004; 35: 151-3.
Chan I, Hamada T, Hardman C et al. Progressive osseous heteroplasia resulting from a new mutation on the GNAS1 gene. Clin Exp Dermatol 2004; 29: 77-80.
Oyama N, Chan I, Neill S et al. Development of antigen-specific ELISA for circulating autoantibodies to extracellular matrix protein 1 (ECM1) in lichen sclerosus. J Clin Invest 2004; 113: 1550-9.
Chan I, Calonje E, Whittaker SJ. Cutaneous Waldenström’s macroglobulinaemia. Clin Exp Dermatol 2003; 28: 491-2.
Chan I, El-Zurghany A, Zendah B et al. Molecular basis of lipoid proteinosis in a Libyan family. Clin Exp Dermatol 2003; 28: 545-8.
Oyama N, Chan I, Neill S et al. Autoantibodies to extracellular matrix protein 1 in lichen sclerosus. Lancet 2003; 362: 118-23.
Hamada T, Chan I, Willoughby CE et al. Common mutations in Arg304 of the p63 gene in EEC syndrome: Lack of genotype-phenotype correlation and implications for mutation detection strategies. J Invest Dermatol 2002; 119:1202-3.
Chan I, Oyama N, Neill S et al. Characterization of autoantibodies to extracellular matrix protein 1 (ECM1) in lichen sclerosus. Clin Exp Dermatol 2004; 29: 499-504.
Chan I, Sethuraman G, Sharma VK et al. Molecular basis of lipoid proteinosis in two Indian siblings. J Dermatol 2004; 31: 764-6.
Chan I, Bingewar G, Patil K et al. An Indian child with lipoid proteinosis resulting from a recurrent frameshift mutation (507delT) in the extracellular matrix protein 1 (ECM1) gene. Br J Dermatol 2004; 151: 726-7.
Chan I, Harper JI, Mellerio JE et al. ADULT ectodermal dysplasia syndrome resulting from the missense mutation R298Q in the p63 gene. Clin Exp Dermatol 2004; 29: 669-72.
Reference number 4436429
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.